Kamboj M, Laracy JC, Usiak S, Babady NE, et al. Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal antibody resistant variants. J Infect 2023 Jul 13:S0163-4453(23)00378-X. doi: 10.1016/j.jinf.2023.
PMID: 37451364